Multiple sclerosis is unique and requires personalized care

I’ve always liked the phrase “go with what you know.” I suppose I understood it to mean “stick to what you’re good at” or simply, “stay in your lane.” Recently, though, I stumbled on a slightly different meaning that I like even better.

“Use knowledge you already have as a means to learn and understand new things.”

Of course, that’s from a website that has nothing at all to do with multiple sclerosis (MS). Regardless, it inspires me to keep learning about and trying to understand MS through knowledge I already have. That’s why so many of my examples are from my years in the military. It’s what I know best.

Recommended Reading

May 10, 2023 News by Steve Bryson, PhD

Omega-3 fatty acid transporter vital for myelin sheath production: Study

Different factors to consider

When I trained as a U.S. Army Special Forces medic, we learned early on the protocols taught to civilian paramedics. These methods are among the best trauma life support techniques in the world, but are designed for a certain environment.

In this environment, the scene is secured as well as possible, bright light is provided as needed, and there is generally a dedicated means of transportation. The injuries are mostly blunt trauma, but no matter what is encountered, supplies are usually plentiful. Time is still the most important factor, but the goal is to deliver the patient to a higher level of care within an hour.

Combat trauma is different. The scene may be very unsecured. Lighting of any kind may not be feasible because it attracts unwanted attention. Transportation is whatever is available, including being carried over someone’s shoulder or dragged behind cover. Supplies are limited to what can be carried, injuries are unique to the situation, and time is extremely variable.

With those factors in mind, a different set of protocols was developed and taught. Rather than the golden standard of civilian paramedic training, the military introduced Tactical Combat Casualty Care (TCCC).

One set of methods or standards isn’t better than the other, and they actually overlap in many areas. The idea was to employ different techniques and tactics for a different situation to lead to a better outcome.

Have you guessed where I’m going with all of this rambling?

Multiple sclerosis is different. It’s different from any other disease and unique to the individual. The environment, wounds encountered, timeline, and scene are not the norm and can’t be addressed in a standard way.

No two diagnosis stories start or end the same. The symptoms that drove me to look for an answer are different than yours, as was the time it took to get an answer. Each of us has wounds (lesions) unique to this disease and in size and location. Our treatments and the providers who treat us are generally specific to MS. Even our various therapies — physical, occupational, speech, and others — must be tailored to the disease.

I’m at a loss as to a perfect set of protocols to care for our very imperfect disease. I don’t like being unique in this case, but it’s plain to see that we need unique tactics. Until a cure is found, we need variable protocols to care for our consistently inconsistent disease.

I tried to come up with an abbreviation like TCCC for multiple sclerosis care. Unfortunately, all my ideas either didn’t roll off the tongue well or spelled something vulgar. If you have an idea, please share in the comments below.

Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, Bionews, and are intended to spark discussion about issues pertaining to multiple sclerosis.